The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels - PubMed (original) (raw)
Multicenter Study
. 2007 Dec;92(12):1607-14.
doi: 10.3324/haematol.11643.
Affiliations
- PMID: 18055983
- DOI: 10.3324/haematol.11643
Free article
Multicenter Study
The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels
Melanie J Percy et al. Haematologica. 2007 Dec.
Free article
Abstract
Background and objectives: Idiopathic erythrocytosis (IE) is characterized by erythrocytosis in the absence of megakaryocytic or granulocytic hyperplasia, and is associated with variable serum erythropoietin (Epo) levels. Most patients with IE lack the JAK2 V617F mutation that occurs in the majority of polycythemia vera patients. Four novel JAK2 mutant alleles have recently been described in patients with V617F-negative myeloproliferative disorders presenting with erythrocytosis. The aims of this study were to assess the prevalence of JAK2 exon 12 mutations in IE patients, and to determine the associated clinicopathological features.
Design and methods: A cohort of 58 IE patients with low to normal serum Epo levels and no known causative mutation were identified from 181 individuals diagnosed with IE. Patients' DNA samples were screened for the presence of a JAK2 exon 12 mutation by allele-specific polymerase chain reaction and sequencing. Bone marrow trephines were examined for morphological abnormalities and the erythroid activity assessed immunohistochemically.
Results: Eight mutation-positive cases were identified, including one with a previously undescribed mutant JAK2 exon 12 allele and another with biallelic involvement. The hematologic features of mutation-positive and mutation-negative patients were similar, although Epo-hypersensitive erythroid progenitors occurred exclusively in patients with an exon 12 mutation (p=0.0002; n=15). Patients' bone marrows were moderately hypercellular, as the result of erythroid hyperplasia, and several had mild megakaryocyte atypia.
Interpretation and conclusions: JAK2 exon 12 mutations were detected in 27% of patients with low serum Epo levels, all of whom had Epo-independent erythroid progenitors. Consequently, IE patients presenting with either of these features should be tested for the presence of a JAK2 mutation.
Comment in
- Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
Cazzola M. Cazzola M. Haematologica. 2007 Dec;92(12):1585-9. doi: 10.3324/haematol.11506. Haematologica. 2007. PMID: 18055979 Review. No abstract available.
Similar articles
- Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
Cazzola M. Cazzola M. Haematologica. 2007 Dec;92(12):1585-9. doi: 10.3324/haematol.11506. Haematologica. 2007. PMID: 18055979 Review. No abstract available. - Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
Lakey MA, Pardanani A, Hoyer JD, Nguyen PL, Lasho TL, Tefferi A, Hanson CA. Lakey MA, et al. Am J Clin Pathol. 2010 Jun;133(6):942-8. doi: 10.1309/AJCP3Z2AKUWRGTNM. Am J Clin Pathol. 2010. PMID: 20472853 - JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR. Scott LM, et al. N Engl J Med. 2007 Feb 1;356(5):459-68. doi: 10.1056/NEJMoa065202. N Engl J Med. 2007. PMID: 17267906 Free PMC article. - Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.
Ohyashiki JH, Hisatomi H, Shimizu S, Sugaya M, Ohyashiki K. Ohyashiki JH, et al. Jpn J Clin Oncol. 2009 Aug;39(8):509-13. doi: 10.1093/jjco/hyp048. Epub 2009 Jun 2. Jpn J Clin Oncol. 2009. PMID: 19491085 - Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W. Michiels JJ, et al. Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21. Pathol Biol (Paris). 2007. PMID: 16919893 Review.
Cited by
- Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Tomuleasa C, Tigu AB, Munteanu R, Moldovan CS, Kegyes D, Onaciu A, Gulei D, Ghiaur G, Einsele H, Croce CM. Tomuleasa C, et al. Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review. - Diagnosis- and Prognosis-Related Gene Alterations in _BCR::ABL1_-Negative Myeloproliferative Neoplasms.
Morishita S, Komatsu N. Morishita S, et al. Int J Mol Sci. 2023 Aug 21;24(16):13008. doi: 10.3390/ijms241613008. Int J Mol Sci. 2023. PMID: 37629188 Free PMC article. Review. - Genetic Background of Polycythemia Vera.
Regimbeau M, Mary R, Hermetet F, Girodon F. Regimbeau M, et al. Genes (Basel). 2022 Apr 2;13(4):637. doi: 10.3390/genes13040637. Genes (Basel). 2022. PMID: 35456443 Free PMC article. Review. - JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.
Patel AB, Franzini A, Leroy E, Kim SJ, Pomicter AD, Genet L, Xiao M, Yan D, Ahmann JM, Agarwal AM, Clair P, Addada J, Lambert J, Salmon M, Gleich GJ, Cross NCP, Constantinescu SN, O'Hare T, Prchal JT, Deininger MW. Patel AB, et al. Blood. 2019 Dec 26;134(26):2388-2398. doi: 10.1182/blood.2019001385. Blood. 2019. PMID: 31697804 Free PMC article. - Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from Pakistan.
Akram AM, Kausar H, Chaudhary A, Khalid AM, Shahzad MM, Akhtar MW, Sabar MF, Sajid N, Anazi NA, Aleem A, Iqbal Z. Akram AM, et al. J Cancer. 2018 Oct 21;9(23):4341-4345. doi: 10.7150/jca.27414. eCollection 2018. J Cancer. 2018. PMID: 30519338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous